Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Thymic aplasia 1Prostatic Neoplasms 1Lymphoma, Follicular 1Immunologic Deficiency Syndromes 1Erectile Dysfunction 1Dermatitis, Atopic 1Carcinoma, Hepatocellular 1

Interventions

Sirolimus 3aldesleukin 2Tacrolimus 2Cyclosporine 2relatlimab 1oxycodone-acetaminophen 1abobotulinumtoxinA 1Vemurafenib 1Sodium Chloride 1Prednisone 1Nivolumab 1Mycophenolic Acid 1Meloxicam 1Ipilimumab 1Interleukins 1Interleukin-2 1Fluorouracil 1Everolimus 1Bleomycin 1Azathioprine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Skin Neoplasms × Tacrolimus × Clear all
NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated
44 enrolled 7 charts
Dermatologic

Skin Neoplasms

NCT00129961 2012-04-11

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 4 Completed
86 enrolled 22 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡